“I’m starting to think that the government hates when young people are having fun,” a friend sardonically remarked to me recently in reference to the Food and Drug Administration’s continued campaign against the sale of nicotine products. While said in jest, the quip seemed to contain an element of truth.
Recently, a legal challenge has forced the popular nicotine product Zyn to halt its online sales. This development follows the FDA’s decision to issue 119 warnings to retailers who carry Zyn nicotine pouches for allegedly selling the product to minors. Coincidentally, these actions occurred only a few months after Senate Majority Leader Chuck Schumer condemned the product, imploring the FDA to investigate further.
In light of these actions, it seems Zyn has entered the crosshairs of the FDA’s jihad against nicotine consumption.
Not too long ago in 2018, the FDA issued a warning against flavored nicotine products, and in 2020 banned the sale of most flavored vape pods, slashing the popular American retailer Juul’s sales. A few years later, the FDA ordered a halt on all Juul products, including their two remaining flavors, tobacco and menthol.
These FDA policies destroyed Juul’s business and created a massive gap in the market. Conveniently for some, there hasn’t been a crackdown on disposable flavored nicotine devices from foreign countries (often China), such as Breeze Vapes and Geek Bars. They immediately took Juul’s place and have faced no ban, continuing to be popular to this day.
Zyn, a discreet flavored nicotine pouch, has grown
